Atlas Trials

Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

Clinical trial NCT05405114 · COMPLETED

Trial details

NCT number
NCT05405114
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2022-07-07
Primary completion
2025-07-24
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.